Legal Storm Clouds Gather as Pfizer Faces Critical Court Decision

The pharmaceutical behemoth Pfizer confronts one of its most significant legal challenges in recent memory today. A Florida court is set to rule on whether hundreds of women can proceed with litigation against the company regarding alleged undisclosed brain tumor risks associated with one of its products. This legal development emerges at a particularly vulnerable moment for the drugmaker, which continues to grapple with substantial revenue declines following the pandemic boom and now faces potential new liability precisely when it’s urgently seeking fresh growth avenues.

Pfizer’s current legal worries are compounded by severe financial headwinds. After achieving record-breaking revenue exceeding $100 billion in 2022, the company experienced a dramatic 36.6% contraction in 2024, with total revenue falling to $63.63 billion. Both its COVID-19 vaccine and the... Read more...